Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma

In an open-label, multicenter phase II study of Japanese patients with cytokine-refractory metastatic renal cell carcinoma, axitinib showed substantial antitumor activity with an acceptable safety profile. Here, we report overall survival and updated efficacy and safety results. Sixty-four Japanese...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Eto, Masatoshi, Uemura, Hirotsugu, Tomita, Yoshihiko, Kanayama, Hiroomi, Shinohara, Nobuo, Kamei, Yoichi, Fujii, Yosuke, Umeyama, Yoshiko, Ozono, Seiichiro, Naito, Seiji, Akaza, Hideyuki
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4317969/
https://ncbi.nlm.nih.gov/pubmed/25283266
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados